Introduction and purposes. Ocular implant with radioactive sources of iodine 125 is a technical of brachyterapy. It allows keeping an eye vision with a low percentage of secondary effects, which depend on situation and size of tumour. It is applied for treatment of intraocular and malignant tumours as well as some non-malignant processes when another therapeutic alternatives fails or can not be...

Many specialists encounter and treat orbital fractures. The management of these fractures is often challenging due to the impact that they can have on vision. Acute treatment involves a thorough clinical examination and management of concomitant ocular injuries. The clinical and radiographic findings for each individual patient must then be analyzed for the need for surgical intervention. Defor...

A 60-year-old female came to our hospital with defective vision due to persistent diabetic macular edema and was treated with intravitreal ozurdex implant in the right eye. Three days later, the patient presented with diminution of vision, ocular pain, congestion, and hypopyon with no fundus view. B-scan ultrasonography showed vitritis, and diagnosis of endophthalmitis was made. Subsequently, 2...

Various strategies for ocular drug delivery are considered; from basic formulation techniques for improving availability of drugs; viscosity enhancers and mucoadhesives aid drug retention and penetration enhancers promote drug transport into the eye. The use of drug-loaded contact lenses and ocular inserts allows drugs to be better placed where they are needed for more direct delivery. Developm...

Past Ocular History  Congenital cataracts OU  Chronic angle closure glaucoma OS  Anophthalmos OD  Pseudophakia OS Ocular surgery OD  Needling of congenital cataract 1938  Enucleation 1954  Secondary orbital implant 4/2011 Ocular surgery OS  Needling of congenital cataract 1938  DSAEK/Phaco/Intraocular lens x 2/Anterior vitrectomy 2/2007  Ahmed valve Seton model FP-7 with scleral patch...

Drug therapy intervention plays a major role in the management of many ocular diseases. However, precise delivery of pharmaceutical solutions to a specified target within the body is an ongoing challenge in many areas of drug delivery. Current routes of ocular treatment (topical, systemic or intraocular injections) have limited efficacy due to physiological barriers, potential side effects, and...

OBJECTIVE To determine the orbital tolerance of a microporous implant fitted with an integrated stainless steel post and the enhanced motility associated with magnetic coupling of the prosthetic and the implant in a rabbit model. METHODS Six New Zealand white rabbits underwent primary enucleation with implantation of a 12-mm microporous polyethylene implant with a 2 x 3-mm stainless steel pos...

PURPOSE To report our experience with dexamethasone 0.7 mg sustained-release intravitreal implant (Ozurdex(®); Allergan, Inc, Irvine, CA) in noninfectious posterior uveitis. METHODS A retrospective chart review of patients with noninfectious uveitis treated with sustained-release dexamethasone 0.7 mg intravitreal implant was performed. Complete ophthalmic examination including signs of inflam...